These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21518979)

  • 21. Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia.
    Amano Y; Nishimoto T; Tozawa Ri; Ishikawa E; Imura Y; Sugiyama Y
    Eur J Pharmacol; 2003 Apr; 466(1-2):155-61. PubMed ID: 12679152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus.
    Kahlon AK; Roy S; Sharma A
    J Biomol Struct Dyn; 2010 Oct; 28(2):201-10. PubMed ID: 20645653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Transporters in the Hepatic Uptake of TAK-475 M-I, a Squalene Synthase Inhibitor, in Rats and Humans.
    Ebihara T; Takeuchi T; Moriya Y; Tagawa Y; Kondo T; Moriwaki T; Asahi S
    Drug Res (Stuttg); 2016 Jun; 66(6):316-23. PubMed ID: 27011383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Statins and cardiovascular disease prevention: use and prospective].
    Moulin P
    Nephrologie; 2000; 21(7):379-80. PubMed ID: 11200617
    [No Abstract]   [Full Text] [Related]  

  • 25. What you should know about: statins.
    Harv Health Lett; 2012 Oct; 37(12):7. PubMed ID: 23243693
    [No Abstract]   [Full Text] [Related]  

  • 26. Statins: putting the benefit/risk into perspective.
    Shepherd J
    Int J Clin Pract Suppl; 2003 Oct; (137):27-33. PubMed ID: 14649699
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibitors of squalene biosynthesis and metabolism.
    Abe I; Tomesch JC; Wattanasin S; Prestwich GD
    Nat Prod Rep; 1994 Jun; 11(3):279-302. PubMed ID: 15200015
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment with statins for the reduction of cardiovascular risk].
    Chiariello M
    Ital Heart J Suppl; 2001 Mar; 2(3):221-3. PubMed ID: 11307779
    [No Abstract]   [Full Text] [Related]  

  • 29. Squalene synthase inhibition: a novel target for the management of dyslipidemia.
    Davidson MH
    Curr Atheroscler Rep; 2007 Jan; 9(1):78-80. PubMed ID: 17169251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Other therapies for reducing low-density lipoprotein cholesterol: medications in development.
    Stein EA
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):99-119. PubMed ID: 19217514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What you need to know about statins. Statins are the most commonly-prescribed drug and have revolutionized heart health.
    Heart Advis; 2009 Apr; 12(4):6-7. PubMed ID: 20387254
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipid lowering beyond statins and methodological issues in cardiovascular clinical trials.
    Crea F
    Eur Heart J; 2022 Apr; 43(14):1365-1368. PubMed ID: 35388411
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
    Ugawa T; Kakuta H; Moritani H; Shikama H
    Br J Pharmacol; 2002 Mar; 135(6):1572-8. PubMed ID: 11906972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of TAK-475, a Squalene Synthase Inhibitor, in Rats and Dogs.
    Ebihara T; Teshima K; Kondo T; Tagawa Y; Moriwaki T; Asahi S
    Drug Res (Stuttg); 2016 Jun; 66(6):287-92. PubMed ID: 26839207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.
    Gotto AM
    Circulation; 2006 Sep; 114(12):1310-4; discussion 1314. PubMed ID: 16982952
    [No Abstract]   [Full Text] [Related]  

  • 36. Statins for patients with type 2 diabetes.
    Auer J; Berent R; Weber T; Eber B
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1933-4. PubMed ID: 15566997
    [No Abstract]   [Full Text] [Related]  

  • 37. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.
    Kojro E; Füger P; Prinzen C; Kanarek AM; Rat D; Endres K; Fahrenholz F; Postina R
    J Alzheimers Dis; 2010; 20(4):1215-31. PubMed ID: 20413873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squalene synthase inhibitors: their potential as hypocholesterolaemic agents.
    Watson NS; Procopiou PA
    Prog Med Chem; 1996; 33():331-78. PubMed ID: 8776946
    [No Abstract]   [Full Text] [Related]  

  • 39. Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins.
    Barter PJ; Rye KA
    Circulation; 2006 Sep; 114(12):1315-20; discussion 1320. PubMed ID: 16982953
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary prevention for cardiovascular diseases: can statins replace aspirin?
    Abdul Hadi M; Ming LC; Awaisu A
    Med Princ Pract; 2011; 20(6):584. PubMed ID: 21986022
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.